# A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes

> **NCT00001062** · PHASE1 · COMPLETED · sponsor: **National Institute of Allergy and Infectious Diseases (NIAID)** · enrollment: 25 (—)

## Conditions studied

- Cytomegalovirus Retinitis
- HIV Infections

## Interventions

- **DRUG:** Ganciclovir

## Key facts

- **NCT ID:** NCT00001062
- **Lead sponsor:** National Institute of Allergy and Infectious Diseases (NIAID)
- **Sponsor class:** NIH
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** —
- **Primary completion:** —
- **Final completion:** 1998-01
- **Target enrollment:** 25 (—)
- **Last updated:** 2021-11-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00001062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00001062, "A Study of Ganciclovir in the Treatment of Cytomegalovirus of the Eyes". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT00001062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*